Review Article
The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance
Table 2
Nrf2 and HO-1 upregulation in tumours.
| Type of tumor | Nrf2 | HO-1 | Reference |
| Glioblastoma stem cells (GSCs) | ↑ | — | [101] | Lung cancer (NSCLC) | ↑ | — | [92, 94] | Ovarian carcinoma | ↑ | — | [85] |
| Bladder cancer | — | ↑ | [121] | Chronic myeloid leukemia | — | ↑ | [139] | Colon adenocarcinoma | — | ↑ | [135] | Colorectal cancer | — | ↑ | [118] | Fibrosarcoma | — | ↑ | [131] | Gastric cancer | — | ↑ | [138] | Hepatocellular carcinoma (HCC) | — | ↑ | [127] | Kaposi sarcoma | — | ↑ | [128] | Lung cancer (NSCLC) | — | ↑ | [120, 122, 134, 137] | Melanoma | — | ↑ | [123, 131] | Oral squamous cell carcinoma | — | ↑ | [125] | Pancreatic cancer | — | ↑ | [119, 124, 126, 133] |
| Breast cancer | ↑ | ↑ | [86] | Cervical cancer | ↑ | ↑ | [152] | Chronic myeloid leukemia | ↑ | ↑ | [136] | Esophageal squamous carcinoma | ↑ | ↑ | [82] | Gallbladder cancer | ↑ | ↑ | [79] | Glioblastoma | ↑ | ↑ | [100, 155] | Glioblastoma stem cells (GSCs) | ↑ | ↑ | [100] | Hepatoma | ↑ | ↑ | [152] | Lung cancer (NSCLC) | ↑ | ↑ | [87, 89, 152] | Malignant B lymphocytes | ↑ | ↑ | [154] | Mammosphere stem cells (MSC) | ↑ | ↑ | [102] | Multiple myeloma | ↑ | ↑ | [153] | Neuroblastoma | ↑ | ↑ | [90, 91] | Ovarian carcinoma cells | ↑ | ↑ | [156] | Prostate cancer | ↑ | ↑ | [88] | Renal cancer | ↑ | ↑ | [117] |
|
|